Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

Annual Report and Accounts for the year ended 30 June 2012

6. Profit Before Taxation

The following items have been included in arriving at profit before taxation:

Cost of inventories recognised as an expense323,478298,105
Impairment of inventories included in above figure942558
Depreciation of property, plant and equipment
— owned assets1,3811,288
— under finance leases203247
Amortisation of intangible assets12,76210,362
Loss on disposal of intangible assets47
(Profit)/loss on disposal of property, plant and equipment(45)1
Impairment of receivables207573
Operating lease rentals payable4,0643,905
Research and development expenditure as incurred5,7355,221
Auditor's remuneration1,0731,087
Analysis of total fees paid to the Auditor:
Audit of these financial statements5042
Audit of financial statements of subsidiaries pursuant to legislation225185
Other services pursuant to legislation2951
Other services relating to taxation103237
Other services relating to acquisitions666572

We use cookies and track users anonymously, check this box and save to disable. We are inferring consent by continuing.